As the cannabis industry continues to evolve, pioneers like FloraWorks and its CEO, Micah Hogan, are pushing the boundaries of what is possible with the use of minor cannabinoids. With a focus on research and development, FloraWorks is working to integrate cannabinoids like CBN into mainstream health and wellness products, bringing a new level of efficacy and safety to the industry. This was the focus of the latest episode of Cannabis Pros And Marketing Masters.
Hogan’s journey into the cannabis industry began unexpectedly, as he was introduced to a friend who had started an extract company. Recognizing an opportunity, Hogan began selling oil out of the back of his vehicle, eventually transitioning to a role with a distribution company in Southern Oregon. However, it was his work with a distribution company that truly solidified his passion for the industry, as he saw firsthand the impact that cannabinoids could have on people’s lives.
“I was amazed by the potential of cannabinoids to improve people’s health and wellness,” Hogan said. “But I also saw the challenges that the industry faced, particularly in terms of educating consumers about the benefits of different products.”
As the industry has grown, Hogan has remained committed to his roots and continues to prioritize research and development. With FloraWorks, he has developed a line of products that focus on the use of minor cannabinoids, particularly CBN. This move has been met with enthusiasm from companies like Wild, Groon, and TopMind, who have seen significant success with CBN-based products.
“The sales data speaks for itself,” Hogan said. “People are looking for products that can help them achieve specific effects, like sleep or energy. CBN is a natural fit for this, and we’ve seen tremendous success with our product.”
But Hogan’s ambitions go beyond just FloraWorks. He sees the potential for cannabinoids to be incorporated into mainstream health and wellness products, partnering with companies like Garden of Life and Gaia Herbs to bring this vision to life.
“We’re not just suppliers,” Hogan said. “We’re originators. We work closely with our partners to ensure that our products meet their high standards and to educate them about the benefits of CBN.”
As the industry continues to evolve, Hogan remains confident that minor cannabinoids will play a key role in shaping the future of cannabis. With FloraWorks at the forefront, he is pushing the boundaries of what is possible, working to integrate these powerful compounds into mainstream health and wellness products.
“Cannabinoids have the potential to revolutionize the health and wellness industry,” Hogan said. “We’re just getting started.”
In a statement, Hogan emphasized the importance of rigorous science in the development of cannabinoids.
“At FloraWorks, we’re committed to leading the industry with research-driven products. We believe that the science is clear: minor cannabinoids like CBN have the potential to transform people’s lives.”
FloraWorks is poised to continue its leadership role in the cannabis industry, driven by a passion for research and development and a commitment to excellence. As the industry continues to evolve, one thing is clear: minor cannabinoids are here to stay, and FloraWorks is at the forefront of this movement.
Watch the full episode here.
